Filter
58
Filtered Results: 58
Text search:
SIAPS
Featured
Recommendations
5
New Publications
25
Language
Document type
No document type
37
Guidelines
8
Studies & Reports
7
Manuals
3
Resource Platforms
2
Training Material
1
Countries / Regions
Ethiopia
7
Philippines
6
Namibia
5
Bangladesh
4
Congo, Democratic Republic of
3
Rwanda
3
South Africa
3
Guinea
2
Thailand
2
Benin
2
Western and Central Europe
2
Eastern Europe
2
Cameroon
1
Uganda
1
Haiti
1
Nepal
1
South Sudan
1
Jordan
1
Syria
1
Kenya
1
Cambodia
1
Indonesia
1
Mozambique
1
Eswatini/ Swaziland
1
Brazil
1
Ukraine
1
Lesotho
1
Yemen
1
Middle East and North Africa
1
Asia
1
Authors & Publishers
Publication Years
Category
Countries
34
Women & Child Health
3
Clinical Guidelines
2
Key Resources
2
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Pharmacy
10
AMR
8
TB
6
Ebola
2
HIV
2
Conflict
1
NCDs
1
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues ...
Nosocomial or health-facility-acquired infections are a serious issue, representing one of the most significant causes of morbidity and mortality in healthcare systems and consuming many scarce resources, especially in developing countries. Although much has been done, particularly in the hospital s...
Improving Infection Prevention and Control Practices at Health Facilities in Resource-Limited Settings
recommended
SIAPS Technical Report. This report summarizes key accomplishments and lessons learned in implementing SIAPS’ approach to improving IPC practices in four countries: South Africa, Namibia, Jordan, ...
Accessed July 2014
Curriculum reform efforts to enhance training on rational medicine use (RMU) and AMR should pay particular attention to ensuring that the right topics are integrated and the right teaching-learning methodologies are adopted.
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and us...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...
The ICAT is a simple and practical approach for assessing the adequacy of existing infection prevention and control practices and provides specific recommendations for improving practices and monitoring their effectiveness over time
Soumis à l’Agence des États-Unis pour le développement international par le programme SIAPS (Systems for Improved Access to Pharmaceuticals and Services ou Programme des systèmes pour l’amélioration de l’accès aux produits et services ph...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arl...
Pharmadex is a web-based tool that helps streamline and track medicines registration for a national drug regulatory authority. This tool was created by the USAID-funded Systems for Improved Access to Pharmaceutical and Services (SIAPS) Program imple...
Stock-outs of antimalarials cause unnecessary deaths among an estimated 219 million people afflicted worldwide. Good pharmaceutical information systems can avoid stock-outs with timely, accurate data and high reporting rates that ensure the continuous availability of critically-needed antimalarials....
ERJ Open Res 2017; 3: 00002-2017
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, tim...
